TIDMCLIN TIDMBARC
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI")
STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation CLINIGEN GROUP PLC
to whose
relevant securities this form
relates:
(c) Name of the party to the offer with Triley Bidco Limited (a
which exempt newly-formed company indirectly
owned by Triton Funds)
principal trader is connected
(d) Date position held/dealing 05 January 2022
undertaken:
(e) In addition to the company in 1(b) NO
above, is the exempt principal
trader making disclosures in respect
of any other party to the offer?
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: 0.1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 800,448 0.60% 432,195 0.32%
(2) Cash-settled derivatives:
393,922 0.30% 683,801 0.51%
Stock-settled derivatives
(3) (including options)
and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,194,370 0.90% 1,115,996 0.84%
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors'
and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of Purchase/sale Total number Highest price Lowest price
relevant of per unit per unit
security securities paid/received paid/received
0.1p ordinary Purchase 624,164 9.2252 GBP 9.1638 GBP
0.1p ordinary Sale 75,889 9.2254 GBP 9.1707 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.1p ordinary SWAP Long 789 9.1801 GBP
0.1p ordinary CFD Long 2,175 9.2250 GBP
0.1p ordinary SWAP Long 7,307 9.1871 GBP
0.1p ordinary SWAP Long 9,563 9.2019 GBP
0.1p ordinary SWAP Short 8 9.1634 GBP
0.1p ordinary SWAP Short 17 9.1759 GBP
0.1p ordinary SWAP Short 25 9.1639 GBP
0.1p ordinary SWAP Short 89 9.1780 GBP
0.1p ordinary SWAP Short 133 9.1637 GBP
0.1p ordinary SWAP Short 146 9.1775 GBP
0.1p ordinary SWAP Short 198 9.1657 GBP
0.1p ordinary SWAP Short 270 9.1788 GBP
0.1p ordinary SWAP Short 296 9.1783 GBP
0.1p ordinary SWAP Short 333 9.1638 GBP
0.1p ordinary SWAP Short 344 9.1786 GBP
0.1p ordinary SWAP Short 546 9.1733 GBP
0.1p ordinary SWAP Short 690 9.1785 GBP
0.1p ordinary SWAP Short 722 9.1770 GBP
0.1p ordinary SWAP Short 832 9.1773 GBP
0.1p ordinary SWAP Short 1,127 9.1777 GBP
0.1p ordinary SWAP Short 1,200 9.1789 GBP
0.1p ordinary SWAP Short 1,324 9.2252 GBP
0.1p ordinary SWAP Short 2,280 9.2150 GBP
0.1p ordinary CFD Short 2,368 9.1775 GBP
0.1p ordinary SWAP Short 4,015 9.1774 GBP
0.1p ordinary CFD Short 4,375 9.2250 GBP
0.1p ordinary SWAP Short 4,531 9.1749 GBP
0.1p ordinary SWAP Short 82,291 9.1665 GBP
0.1p ordinary SWAP Short 459,949 9.1745 GBP
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type e.g. Expiry Option
relevant description purchasing, securities price American, date money
security e.g. call selling, to which per European paid/
option varying option unit etc. received
etc. relates per
unit
(ii) Exercise
Class of Product Exercising/ Number of Exercise price
relevant description exercised securities per unit
security e.g. call against
option
(d) Other dealings (including subscribing for new
securities)
Class of relevant Nature of dealing Details Price per unit (if
security e.g. subscription, applicable)
conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the exempt
principal trader making the disclosure and any party to the offer or any
person acting in concert with a party to the offer: Irrevocable commitments
and letters of intent should not be included. If there are no such agreements,
arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the exempt principal trader making the disclosure and any other person
relating to: (i) the voting rights of any relevant securities under any
option; or (ii) the voting rights or future acquisition or disposal of any
relevant securities to which any derivative is referenced: If there are no
such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open
Positions) attached? NO
Date of disclosure: 6 Jan 2022
Large Holdings Regulatory
Contact name: Operations
Telephone number: 020 3134 7213
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20220106005429/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC
Copyright Business Wire 2022
(END) Dow Jones Newswires
January 06, 2022 04:21 ET (09:21 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2023 to Jul 2024